Sensato Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Sensato Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-99,764	Closed	-$10.6M	–	116
2016 Q2	$10.6M	Sell	99,764 -13,532	-12%	-$1.57M	1.71%	28
2016 Q1	$13M	Buy	113,296 +20,219	+22%	+$2.37M	2.31%	18
2015 Q4	$13.3M	Buy	+93,077	New	+$10.7M	2.49%	16

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Sensato Investors's CBPO Position: Q3 2016 in Review

Sensato Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 99,764 shares — an estimated $10.6M sold.

Sensato Investors first reported a position in CBPO in Q4 2015 and held it in 3 quarters. The position peaked at $13.3M in Q4 2015. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

Sensato Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
Sensato Investors sold 99,764 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $10.6M.
Sensato Investors first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 3 quarters.
Sensato Investors's China Biologic Products Holdings, Inc. position peaked at $13.3M in Q4 2015.
162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on Sensato Investors's 13F filing for Q3 2016, filed 15 Nov 2016.